| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 07/21/1993 | EP0179887B1 Adhesin antigens, antibodies and dna fragment encoding the antigen, methods and means for diagnosis and immunization etc. |
| 07/21/1993 | CN1074437A Narrow poly-and mono-dispersed anionic oligomers, and their uses, formulations and process |
| 07/21/1993 | CN1074369A Pharmaceutical composition for inhibiting the infection with aids virus |
| 07/21/1993 | CN1021632C Pharmaceutical composition comprising an organic zinc complex and a process for preparing the active substance |
| 07/20/1993 | US5229418 Histamine H-2 receptor antagonists, antiulcer |
| 07/20/1993 | US5229375 Antitumor agents, antigrowth agents and DNA cleaving property |
| 07/20/1993 | US5229363 Cyclic hexapeptide compounds |
| 07/20/1993 | US5229123 Antifungal agents |
| 07/20/1993 | CA1320444C Pharmaceutical preparations containing iodine having a low water content |
| 07/17/1993 | CA2087112A1 Imidazole derivatives having anti-hiv activity |
| 07/15/1993 | EP0559647A4 Composition and treatment with biologically active peptides and antibiotics which inhibit dna gyrase. |
| 07/15/1993 | DE4200414A1 New quinoline and naphthyridinone-carboxylic acid derivs. |
| 07/14/1993 | EP0557290A4 Treatment of aids dementia, myelopathy, peripheral neuropathy, and vision loss. |
| 07/14/1993 | EP0551034A2 Cephalosporins having in position 7 a benzyloxyimino radical substitute, process for their preparation and their use as medicaments |
| 07/14/1993 | EP0550924A1 2-Pyrrolidinone derivatives as HIV protease inhibitors |
| 07/14/1993 | EP0550903A1 Quinolone- and naphthyridone carboxylic acid derivatives as antibacterial agents |
| 07/14/1993 | EP0550599A1 Peptides for use in vaccination and induction of neutralizing antibodies against human immunodeficiency virus |
| 07/14/1993 | EP0550589A1 Substituted tricyclic compounds |
| 07/14/1993 | EP0550566A1 Antiproliferative substituted naphthalene compounds |
| 07/14/1993 | EP0550558A1 Acellular vaccine |
| 07/14/1993 | EP0550553A1 Viral defective vaccine produced by transcomplementing cell line |
| 07/14/1993 | EP0550532A1 Dextrin sulfates as anti hiv-1 agents and composition thereof |
| 07/14/1993 | EP0550529A1 Pharmaceutical composition comprising cd4 and a polyanionic anti-hiv agent and use thereof |
| 07/14/1993 | EP0550500A1 NUCLEOTIDE AND AMINO ACID SEQUENCES OF PROTEIN MTP40 OF $i(M. TUBERCULOSIS) AND SYNTHETIC PEPTIDES DERIVED THEREFROM |
| 07/14/1993 | EP0550485A1 DERIVATIVES OF gp160 AND VACCINES BASED ON gp160 OR A DERIVATIVE THEREOF, CONTAINING AN ADJUVANT |
| 07/14/1993 | EP0550465A1 Entamoeba histolytica immunodominant surface antigens |
| 07/14/1993 | EP0550464A1 Antiviral compounds and antihypertensive compounds |
| 07/14/1993 | CN1074218A Quinolone and naphthyridone-carboxylic acid derivatives |
| 07/13/1993 | US5227383 Sampangine analogs |
| 07/13/1993 | CA1320312C Improved vancomycin precipitation process |
| 07/13/1993 | CA1320206C2 Halogen-substituted pyridines |
| 07/13/1993 | CA1320194C Substituted pyrroles |
| 07/10/1993 | CA2086725A1 Sample processing using disinfectant |
| 07/08/1993 | WO1993013202A1 Immunogenic detoxified mutants of cholera toxin and of the toxin lt, their preparation and their use for the preparation of vaccines |
| 07/08/1993 | WO1993013121A1 Gapped 2' modified oligonucleotides |
| 07/08/1993 | WO1993013069A1 Heterocycle-substituted benzylamine derivatives as antiretroviral compounds |
| 07/08/1993 | WO1993013052A1 α-SUBSTITUTED BENZENEMETHANAMINE DERIVATIVES |
| 07/08/1993 | WO1993012800A1 An acidic polycyclic ether useful as an anticoccidial agent and as a growth promotant |
| 07/08/1993 | WO1993012781A2 Creatine analogs having antiviral activity |
| 07/08/1993 | WO1993012776A1 Aids virus infection inhibitor composition |
| 07/08/1993 | WO1993012756A2 Transfection of lung via aerosolized transgene delivery |
| 07/08/1993 | WO1993012654A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | CA2126757A1 Medical uses of trioxolane and diperoxide compounds |
| 07/08/1993 | CA2125676A1 .alpha.-substituted benzenemethanamine derivatives |
| 07/08/1993 | CA2125675A1 Heterocycle-substituted benzenemethanamine derivatives |
| 07/08/1993 | CA2125568A1 Pharmaceutical composition for inhibiting the infection with aids virus |
| 07/08/1993 | CA2125563A1 Creatine analogs having antiviral activity |
| 07/07/1993 | EP0549742A1 USE OF CANPs-INHIBITORS IN PHARMACEUTICAL PREPARATIONS |
| 07/07/1993 | EP0549729A1 Antiviral compounds and antihypertensive compounds |
| 07/07/1993 | EP0549727A1 Carboxylic acid esters of rapamycin |
| 07/07/1993 | EP0549723A1 Packaging cells |
| 07/07/1993 | EP0549711A1 Natural killer stimulatory factor |
| 07/07/1993 | EP0549702A1 Uses of recombinant colony stimulating factor-1 |
| 07/07/1993 | EP0549662A1 Plasmodium liver stage antigens |
| 07/07/1993 | EP0549660A1 Enhancement of glutathione levels with glutamine |
| 07/07/1993 | EP0549615A1 Sugar modified oligonucleotides that detect and modulate gene expression |
| 07/07/1993 | CN1073979A A87689 compounds |
| 07/07/1993 | CN1073944A Tri-substituted tetrahydrofuran antifungals |
| 07/07/1993 | CN1073942A Heterocycle-substituted benzenemethanamine derivatives |
| 07/07/1993 | CN1073936A Alpha-substituted benzenemethanamine derivatives |
| 07/07/1993 | CN1073879A Chicken anaemia agent vaccine |
| 07/07/1993 | CN1073878A Expression of specific immunogens using viral antigens |
| 07/06/1993 | US5225550 Process for the preparation of substituted acyclic nucleosides, and intermediates occurring therein |
| 07/06/1993 | US5225420 Use of tetrahydrothienopyridine derivatives as angiogenesis inhibitors |
| 07/06/1993 | US5225399 Antimicrobial amphiphilic peptides |
| 07/06/1993 | US5225347 Therapeutic ribozyme compositions and expression vectors |
| 07/06/1993 | CA1319932C 2'-alkylidenepyrimidine nucleoside derivatives, process for production thereof, and uses thereof |
| 07/06/1993 | CA1319931C Antiviral antitumor antimetastatic immune system enhancing nucleosides and nucleotides |
| 06/30/1993 | EP0549267A1 Lip treatment composition |
| 06/30/1993 | EP0549040A1 Methods of making 4" derivatives of 9-deoxo-8a-aza-8a-alkyl-8a-homoerythromycin A |
| 06/30/1993 | EP0548798A1 Antiviral agent |
| 06/30/1993 | EP0548790A1 (1'S)-Hydroxyalkyloxapenem-3-carboxylic acids and their use as beta-lactamase inhibitors |
| 06/30/1993 | EP0548314A1 Use of a 2-deoxystreptamine-type antibiotic |
| 06/30/1993 | EP0548248A1 Methods for producing acyloxyacyl hydrolase |
| 06/30/1993 | EP0548234A1 Cloning of chicken anaemia dna |
| 06/30/1993 | EP0548190A1 Novel antibodies for treatment and prevention of infection in animals and man |
| 06/30/1993 | CN1073719A Nanbv diagnostics and vaccines |
| 06/29/1993 | US5223531 1,3,2-dioxathiolan-s-oxide derivatives, method for preparation, and use therefor |
| 06/29/1993 | US5223490 Treating breast cancer |
| 06/29/1993 | US5223271 Lithium treatment |
| 06/29/1993 | US5223263 Viricide complex; aids therapy |
| 06/29/1993 | US5223258 Antiviral disinfecting composition and method of inactivating the aids virus in vitro |
| 06/29/1993 | CA1319697C2 Enantioselective process for producing 1-.beta.-methylcarbapenem antibiotic intermediates |
| 06/29/1993 | CA1319682C Process for the preparation of new oximes derivated from 7-aminothiazolylacetamidocephalosporanic acid |
| 06/29/1993 | CA1319636C Process for the production of macrolide compounds |
| 06/29/1993 | CA1319605C Virucidal agent having wide-spectrum activity |
| 06/25/1993 | CA2086142A1 Prolyl endopeptidase inhibitor |
| 06/24/1993 | WO1993012232A1 Reactive neutralizing human anti-gp120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | WO1993012221A1 Association between a human immunodeficiency virus-related retrovirus and autoimmune disease |
| 06/24/1993 | WO1993012130A1 2'-desoxy-isoguanosines, isoster analogues and isoguanosine derivates and their use |
| 06/24/1993 | WO1993012115A1 7'-amino-naphthazarin antibiotic derivatives |
| 06/24/1993 | WO1993012096A1 Linked cyclic polyamines with activity against hiv |
| 06/24/1993 | WO1993011794A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 06/24/1993 | WO1993011777A1 Amphotericin b composition with enhanced antifungal activity |
| 06/24/1993 | WO1993011775A1 Transdermal azidothymidine |
| 06/24/1993 | WO1993011772A1 Glycosylated steroid derivatives for transport across biological membranes and process for making same |
| 06/24/1993 | WO1993009791A3 Use of amphotericin b derivatives as protease inhibitors |
| 06/24/1993 | CA2126216A1 7'-amino-naphthazarin antibiotic derivatives |
| 06/24/1993 | CA2125396A1 Reactive neutralizing human anti-gp 120 recombinant antibody, dna coding the same and use thereof |
| 06/24/1993 | CA2123780A1 Amphotericin b composition with enhanced antifungal activity |